title: [Efficacy of noninvasive hemolaserotherapy in patients with bronchial asthma and concomitant rhinosinusitis].
abstract: OBJECTIVE
  To study efficacy of low-intensive infrared laser radiation impact on the tympanic membrane in patients with bronchial asthma (BA) and concomitant rhinosinusitis (RS).
  
  
  METHODS
  78 patients with moderate BA of a mixed type and concomitant chronic RS were divided into 3 groups: group 1 patients received medication plus infrared laser radiation of the tympanic membrane and paranasal sinuses; group 2 patients were exposed to supravenous laser radiation (0.63 mcm); group 3 received pharmacotherapy alone. The effect of the treatment was assessed by spirometry, peakflowmetry and paranasal sinuses findings.
  
  
  RESULTS
  The highest response was achieved in group 1 which manifested with positive changes in clinical, device and spirometric data on BA and x-ray data on RS courses. The least effective treatment was observed in group 3.
  
  
  CONCLUSIONS
  Use of infrared laser radiation of the tympanic membrane and paranasal sinuses projection in the treatment of BA patients with RS is effective, nontoxic and easy to use both in hospitals and outpatient departments.
authors.forename: A V
authors.initials: AV
authors.lastname: Nikitin
authors.forename: Iu B
authors.initials: IuB
authors.lastname: Treshchalina
mesh_terms: D000293:Adolescent; D000328:Adult; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D001249:Asthma / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000532:radiotherapy*; D001769:Blood / Q000528:radiation effects*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D028022:Low-Level Light Therapy; D008297:Male; D008875:Middle Aged; D012220:Rhinitis / Q000097:blood / Q000150:complications / Q000532:radiotherapy*; D012852:Sinusitis / Q000097:blood / Q000150:complications / Q000532:radiotherapy*; D016896:Treatment Outcome; D014432:Tympanic Membrane / Q000098:blood supply / Q000528:radiation effects*
chemical_list: D018927:Anti-Asthmatic Agents